Guangdong Transtek Medical Electronics (300562.SZ) stated in investor relations that the company focuses on the digital chronic disease management sector, integrating health IoT, big data, AI, and medical services deeply, accelerating the commercial application of cardiovascular digital chronic disease services. Currently, AI technology is mainly applied in three directions:

(1) Applied in medical diagnosis: Mainly in the remote electrocardiogram service sector - dynamic electrocardiogram diagnosis (self-developed AI algorithm), innovative wearable electrocardiogram devices as carriers, leading AI algorithms as pioneers, focusing on key pain points in the diagnosis and treatment and rehabilitation processes of severe chronic diseases such as heart disease and stroke, providing digital basis for self-management during the recovery period and professional medical services.

(2) Applied in health management services: Currently entering the digital blood pressure management service business, providing long-term sustainable and scientifically effective chronic disease management services to chronic disease patients with a combination of 'remote intelligent monitoring devices + AI digital doctors (combined with cardiovascular AI large models) + health management team.'

(3) Applied in smart medical devices: The approved over-the-counter Transtek hearing aid, a product developed combining AI hearing technology, with supporting AI remote assistance management services, has achieved innovative functions such as adaptive hearing tests, automatic adaptation, and user hearing data tracking.